stockrowHyperion DeFi, Inc. (HYPD) vs Serina Therapeutics, Inc. (SER)
- Hyperion DeFi, Inc. HYPD 2.52 −1.56%
- Serina Therapeutics, Inc. SER 1.40 −15.15%
Hyperion DeFi, Inc. and Serina Therapeutics, Inc. are both Biotechnology companies. Hyperion DeFi, Inc. and Serina Therapeutics, Inc. are of similar size ($41.9M and $39.8M). Hyperion DeFi, Inc. grew revenue faster over the last twelve months: 1,990.6% against −94.2%. Serina Therapeutics, Inc. has the higher net margin (0.00% vs −1,224.5%) and the lower return on invested capital (0.00% vs 2.73%). Across the 17 metrics below, Hyperion DeFi, Inc. leads on 11 and Serina Therapeutics, Inc. on 6.
Valuation
Profitability
| Metric | HYPD | SER | Biotechnology median |
|---|---|---|---|
| Gross margin | 78.35% | 100.00% | 68.51% |
| Operating margin | 314.32% | 0.00% | 0.00% |
| Net margin | (1,224.53%) | 0.00% | 0.00% |
| Free cash flow margin | (5,509.35%) | 0.00% | 0.00% |
| Return on equity | (24.63%) | (306.22%) | (51.96%) |
| Return on assets | (20.32%) | (136.00%) | (46.06%) |
| Return on invested capital | 2.73% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack